| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.07 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |